PTC Therapeutics, Inc. (PTCT)
USD 41.88
(-3.15%)
USD 41.88
(-3.15%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -349.4 Million USD | 20.58% |
| 2022 | -439.92 Million USD | -17.33% |
| 2021 | -374.94 Million USD | 5.76% |
| 2020 | -397.87 Million USD | -106.37% |
| 2019 | -192.79 Million USD | -66.66% |
| 2018 | -115.68 Million USD | -79.94% |
| 2017 | -64.29 Million USD | 51.32% |
| 2016 | -132.05 Million USD | 20.98% |
| 2015 | -167.13 Million USD | -68.12% |
| 2014 | -99.41 Million USD | -118.98% |
| 2013 | -45.39 Million USD | -69.34% |
| 2012 | -26.8 Million USD | -187.66% |
| 2011 | 30.58 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -33.35 Million USD | 26.77% |
| 2024 Q1 | -45.55 Million USD | -1560.03% |
| 2023 FY | -349.4 Million USD | 20.58% |
| 2023 Q4 | 3.12 Million USD | 102.64% |
| 2023 Q1 | -115.21 Million USD | 28.29% |
| 2023 Q3 | -118.16 Million USD | 43.61% |
| 2023 Q2 | -209.54 Million USD | -81.87% |
| 2022 Q2 | -107.56 Million USD | -24.32% |
| 2022 Q3 | -73.48 Million USD | 31.68% |
| 2022 Q4 | -160.65 Million USD | -118.62% |
| 2022 FY | -439.92 Million USD | -17.33% |
| 2022 Q1 | -86.52 Million USD | -2.11% |
| 2021 FY | -374.94 Million USD | 5.76% |
| 2021 Q4 | -84.73 Million USD | 8.97% |
| 2021 Q3 | -93.07 Million USD | 5.5% |
| 2021 Q2 | -98.49 Million USD | -0.35% |
| 2021 Q1 | -98.14 Million USD | -1.84% |
| 2020 Q2 | -187.27 Million USD | -101.39% |
| 2020 FY | -397.87 Million USD | -106.37% |
| 2020 Q1 | -92.99 Million USD | -27.76% |
| 2020 Q3 | -55.13 Million USD | 70.56% |
| 2020 Q4 | -96.37 Million USD | -74.81% |
| 2019 Q2 | -38.75 Million USD | 43.94% |
| 2019 Q3 | -60.47 Million USD | -56.03% |
| 2019 FY | -192.79 Million USD | -66.66% |
| 2019 Q1 | -69.14 Million USD | -53.17% |
| 2019 Q4 | -72.78 Million USD | -20.35% |
| 2018 Q3 | -48.23 Million USD | -765.27% |
| 2018 Q4 | -45.13 Million USD | 6.41% |
| 2018 FY | -115.68 Million USD | -79.94% |
| 2018 Q2 | -5.57 Million USD | 66.71% |
| 2018 Q1 | -16.74 Million USD | -407.1% |
| 2017 Q4 | 5.45 Million USD | 117.65% |
| 2017 FY | -64.29 Million USD | 51.32% |
| 2017 Q1 | -26.35 Million USD | -5.45% |
| 2017 Q2 | -12.49 Million USD | 52.58% |
| 2017 Q3 | -30.89 Million USD | -147.2% |
| 2016 Q1 | -38.44 Million USD | 20.25% |
| 2016 FY | -132.05 Million USD | 20.98% |
| 2016 Q3 | -32.06 Million USD | 12.3% |
| 2016 Q4 | -24.99 Million USD | 22.06% |
| 2016 Q2 | -36.56 Million USD | 4.9% |
| 2015 FY | -167.13 Million USD | -68.12% |
| 2015 Q4 | -48.2 Million USD | -14.13% |
| 2015 Q3 | -42.23 Million USD | -9.34% |
| 2015 Q2 | -38.62 Million USD | -1.46% |
| 2015 Q1 | -38.07 Million USD | -18.12% |
| 2014 Q1 | -14.21 Million USD | 21.45% |
| 2014 FY | -99.41 Million USD | -118.98% |
| 2014 Q3 | -27.6 Million USD | -8.8% |
| 2014 Q4 | -32.23 Million USD | -16.77% |
| 2014 Q2 | -25.36 Million USD | -78.5% |
| 2013 Q3 | -4.27 Million USD | 70.42% |
| 2013 Q4 | -18.09 Million USD | -323.16% |
| 2013 FY | -45.39 Million USD | -69.34% |
| 2013 Q1 | -8.57 Million USD | -42.12% |
| 2013 Q2 | -14.45 Million USD | -68.52% |
| 2012 Q1 | -6.22 Million USD | 0.0% |
| 2012 FY | -26.8 Million USD | -187.66% |
| 2012 Q3 | -7.05 Million USD | 5.91% |
| 2012 Q4 | -6.03 Million USD | 14.47% |
| 2012 Q2 | -7.49 Million USD | -20.55% |
| 2011 FY | 30.58 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -47.298% |
| Alkermes plc | 414.12 Million USD | 184.372% |
| Agenus Inc. | -159.54 Million USD | -118.994% |
| Aptorum Group Limited | -10.52 Million USD | -3220.261% |
| Ardelyx, Inc. | -63.27 Million USD | -452.187% |
| Dyadic International, Inc. | -8.22 Million USD | -4145.602% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -29212.248% |
| Lantern Pharma Inc. | -17.87 Million USD | -1854.416% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -1639.202% |
| Novavax, Inc. | -566.51 Million USD | 38.324% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -378.771% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -325.084% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -1699.324% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -3207.791% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -557.681% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 8.172% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1337.477% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -822.66% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -170.879% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -316.381% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -1892.143% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -693.915% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1306.384% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -151.312% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -23.825% |
| AlloVir, Inc. | -181.33 Million USD | -92.687% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -70.438% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1094.21% |
| Bicycle Therapeutics plc | -189.94 Million USD | -83.948% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -103.398% |
| ChromaDex Corporation | -5.59 Million USD | -6140.436% |
| Chimerix, Inc. | -93.06 Million USD | -275.439% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -675.117% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -201.055% |
| CRISPR Therapeutics AG | -222.53 Million USD | -57.008% |
| Precision BioSciences, Inc. | -43.73 Million USD | -698.889% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -83.403% |
| Fortress Biotech, Inc. | -142.34 Million USD | -145.467% |
| Fortress Biotech, Inc. | -142.34 Million USD | -145.467% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -257.649% |
| ImmuCell Corporation | -5.74 Million USD | -5978.588% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -159.916% |
| Immix Biopharma, Inc. | -16.14 Million USD | -2064.671% |
| Incyte Corporation | 620.52 Million USD | 156.307% |
| Innoviva, Inc. | 176.7 Million USD | 297.727% |
| IO Biotech, Inc. | -91.44 Million USD | -282.098% |
| Jaguar Health, Inc. | -34.29 Million USD | -918.932% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -105.602% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 3025.825% |
| ContextLogic Inc. | -328 Million USD | -6.525% |
| MiMedx Group, Inc. | 37.11 Million USD | 1041.378% |
| MEI Pharma, Inc. | 14.54 Million USD | 2502.709% |
| NextCure, Inc. | -67.63 Million USD | -416.584% |
| Onconetix, Inc. | -36.03 Million USD | -869.629% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -737.613% |
| Opthea Limited | -191.84 Million USD | -82.129% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -12597.101% |
| Vaxcyte, Inc. | -468.04 Million USD | 25.348% |
| PDS Biotechnology Corporation | -43.04 Million USD | -711.709% |
| Precigen, Inc. | -88.92 Million USD | -292.926% |
| Pharming Group N.V. | -4.87 Million USD | -7060.546% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -108.833% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1074.224% |
| PureTech Health plc | -146.19 Million USD | -138.991% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -1605.149% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -48.304% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1337.477% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -27.517% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1092.295% |
| Acelyrin, Inc. | -422.06 Million USD | 17.216% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -2709505.473% |
| Summit Therapeutics Inc. | -89.73 Million USD | -289.367% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -842.699% |
| Senti Biosciences, Inc. | -92.72 Million USD | -276.807% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -204.429% |
| Elevation Oncology, Inc. | -45.44 Million USD | -668.846% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -919.646% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -8763.464% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -10950.032% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -958.121% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -4010.128% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -413.857% |
| Seer, Inc. | -103.46 Million USD | -237.707% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -431.337% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -385.733% |
| ESSA Pharma Inc. | -32.13 Million USD | -987.325% |
| GlycoMimetics, Inc. | -39.27 Million USD | -789.623% |
| GT Biopharma, Inc. | -13.57 Million USD | -2473.674% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -59.383% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -655.366% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 502.481% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -515.589% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -578.371% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -3415.944% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 30.718% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -4965.265% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -589.251% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -34.562% |
| Aptose Biosciences Inc. | -52.35 Million USD | -567.358% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -2322.907% |
| Soligenix, Inc. | -7.69 Million USD | -4438.903% |
| Century Therapeutics, Inc. | -146.54 Million USD | -138.425% |
| Kura Oncology, Inc. | -165.8 Million USD | -110.732% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -273.86% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -4100.048% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -13979.485% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -5288.68% |
| Autolus Therapeutics plc | -195.02 Million USD | -79.155% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -312.727% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -374.331% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -1553.191% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -53.898% |
| GRI Bio, Inc. | -11.38 Million USD | -2968.429% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -7637.468% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -166.327% |
| IGM Biosciences, Inc. | -263.46 Million USD | -32.62% |
| INmune Bio, Inc. | -29.74 Million USD | -1074.816% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -215.872% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -817.66% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2086.583% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -2115.496% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -471.871% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -224.959% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -26.592% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -71.951% |
| Verastem, Inc. | -92.08 Million USD | -279.438% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -641.279% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -89.743% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -195.153% |
| Histogen Inc. | -10.64 Million USD | -3182.928% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -2158.292% |
| Surrozen, Inc. | -45.78 Million USD | -663.22% |
| Organovo Holdings, Inc. | -15.08 Million USD | -2216.068% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -6764.161% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -489.395% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -581.175% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1282.128% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -4477.613% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -103.991% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -621.19% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -346.777% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -2195.56% |
| Apollomics, Inc. | -54.83 Million USD | -537.2% |
| Amarin Corporation plc | -67.58 Million USD | -416.959% |
| Mesoblast Limited | -58.79 Million USD | -494.282% |
| Turnstone Biologics Corp. | -59.03 Million USD | -491.886% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -111.081% |
| Synaptogenix, Inc. | -8.31 Million USD | -4102.648% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -2295.461% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -281.065% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7192.173% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -3856.434% |
| Exelixis, Inc. | 170.88 Million USD | 304.466% |
| Better Therapeutics, Inc. | -38.26 Million USD | -813.183% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -125.329% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 32.433% |
| NLS Pharmaceutics AG | -11.8 Million USD | -2859.263% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -4244.766% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1064.945% |
| Gritstone bio, Inc. | -154.63 Million USD | -125.954% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -407.402% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -1940.536% |
| Avid Bioservices, Inc. | -18.67 Million USD | -1770.661% |
| Insmed Incorporated | -709.62 Million USD | 50.763% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -2126.939% |
| MediWound Ltd. | -15.29 Million USD | -2185.167% |
| OmniAb, Inc. | -69.41 Million USD | -403.323% |
| Alector, Inc. | -151.74 Million USD | -130.264% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -223.571% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -570.02% |
| Zai Lab Limited | -366.57 Million USD | 4.684% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -10.299% |
| Aura Biosciences, Inc. | -84.99 Million USD | -311.105% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -42.323% |
| Immunic, Inc. | -99.22 Million USD | -252.138% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -144.067% |
| Veracyte, Inc. | -85.79 Million USD | -307.252% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -23.983% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -2358.846% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -4972.658% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -1759.251% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 160.39% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1272.734% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1000.474% |
| TG Therapeutics, Inc. | 20.63 Million USD | 1793.413% |
| Galecto, Inc. | -39.9 Million USD | -775.585% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -730.446% |
| Fortrea Holdings Inc. | 63.1 Million USD | 653.727% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -148.782% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1109.925% |
| XBiotech Inc. | -37.51 Million USD | -831.49% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -407.402% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -420.563% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -223.802% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1261.024% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -555.637% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 38.616% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -345.143% |
| Vaxxinity, Inc. | -58.28 Million USD | -499.472% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -236.906% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -1470.125% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -304.326% |
| NexImmune, Inc. | -29.19 Million USD | -1096.89% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -6116.971% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -2296.221% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 108.633% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1272.411% |
| Scopus BioPharma Inc. | -11.71 Million USD | -2882.549% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -174.985% |
| Ainos, Inc. | -13.2 Million USD | -2545.703% |
| Pluri Inc. | -22.15 Million USD | -1476.866% |
| Prothena Corporation plc | -191.03 Million USD | -82.899% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -153.12% |
| Celularity Inc. | -192.28 Million USD | -81.709% |
| Rallybio Corporation | -78.93 Million USD | -342.662% |
| Cue Biopharma, Inc. | -52.14 Million USD | -570.007% |
| MeiraGTx Holdings plc | -137.06 Million USD | -154.924% |
| Omeros Corporation | -164.53 Million USD | -112.364% |
| Humacyte, Inc. | -100.04 Million USD | -249.238% |
| Immunocore Holdings plc | -59.64 Million USD | -485.763% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -1782.655% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1327.121% |
| Blueprint Medicines Corporation | -486.27 Million USD | 28.148% |
| CalciMedica, Inc. | -21.87 Million USD | -1497.266% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -367.991% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -165.735% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -103.977% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -6.883% |
| Pulmatrix, Inc. | -14.74 Million USD | -2270.434% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -877.485% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -293.178% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 32.193% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -417.242% |
| Cytokinetics, Incorporated | -496.2 Million USD | 29.585% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -915.143% |
| Nutriband Inc. | -4.87 Million USD | -7071.743% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -701.142% |
| Vor Biopharma Inc. | -126.03 Million USD | -177.224% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 108.237% |
| Evogene Ltd. | -26.39 Million USD | -1223.944% |
| ProKidney Corp. | -151.52 Million USD | -130.595% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -441.415% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -4442.265% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 42.473% |
| CorMedix Inc. | -48.95 Million USD | -613.68% |
| BioLineRx Ltd. | -49.69 Million USD | -603.107% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -206.029% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -817.74% |
| Atai Life Sciences N.V. | -125.47 Million USD | -178.472% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -327.983% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -329.193% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -40.329% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1036.636% |
| MediciNova, Inc. | -9.9 Million USD | -3429.219% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -176.485% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -4724.356% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1206.521% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -50.718% |
| Biomea Fusion, Inc. | -126.13 Million USD | -177.006% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1129.596% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -82.848% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -51.944% |
| Absci Corporation | -115.51 Million USD | -202.473% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1166.546% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -209.57% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -44.284% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1286.736% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -67.987% |
| Allakos Inc. | -196.05 Million USD | -78.215% |
| Imunon, Inc. | -21.03 Million USD | -1561.412% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -215.732% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 425.686% |
| BioAtla, Inc. | -129.68 Million USD | -169.419% |
| NLS Pharmaceutics AG | -11.8 Million USD | -2859.263% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -2105.403% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -6.61% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -736.731% |
| XOMA Corporation | -41.84 Million USD | -734.931% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -232.014% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -187.585% |
| aTyr Pharma, Inc. | -54.91 Million USD | -536.213% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -299.65% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -102.118% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -37.317% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -1527.7% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -4154.382% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1979.031% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -3951057.013% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 203.504% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -5247.426% |
| UroGen Pharma Ltd. | -65.53 Million USD | -433.145% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -291.364% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -4710.704% |
| Orgenesis Inc. | -53.63 Million USD | -551.432% |
| Entera Bio Ltd. | -8.89 Million USD | -3829.839% |
| GH Research PLC | -41.22 Million USD | -747.61% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1259.118% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -320.698% |
| Xencor, Inc. | -138.63 Million USD | -152.023% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -6678.473% |
| Replimune Group, Inc. | -234.77 Million USD | -48.825% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -1525.797% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -2404.315% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -5247.426% |
| Portage Biotech Inc. | -18.25 Million USD | -1814.217% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -4724.356% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -232.887% |
| OncoCyte Corporation | -25.13 Million USD | -1290.046% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -2990.725% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -2949.665% |
| Purple Biotech Ltd. | 22.27 Million USD | 1668.865% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -4551.251% |
| scPharmaceuticals Inc. | -55.39 Million USD | -530.735% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -1748.914% |
| HilleVax, Inc. | -133.34 Million USD | -162.029% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -2799.842% |
| Tharimmune, Inc. | -9.45 Million USD | -3595.334% |
| Genprex, Inc. | -31.07 Million USD | -1024.362% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -85.661% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1013.561% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -45573.464% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -6314.672% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2218363.428% |
| Savara Inc. | -60 Million USD | -482.269% |
| Curis, Inc. | -48.33 Million USD | -622.921% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1032.955% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -6597.015% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -4701.457% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1182.209% |
| BeiGene, Ltd. | -1.2 Billion USD | 71.07% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -1652.328% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 28.281% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -273.085% |
| Erasca, Inc. | -141.52 Million USD | -146.884% |
| bluebird bio, Inc. | -244.26 Million USD | -43.044% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -7618.224% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 279.696% |
| DBV Technologies S.A. | -76.43 Million USD | -357.141% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -7618.224% |
| Moderna, Inc. | -4.23 Billion USD | 91.757% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -720.019% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -5393.742% |
| Molecular Templates, Inc. | -10.46 Million USD | -3238.448% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -419.657% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 7.257% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -143.807% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -572.017% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -126.089% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -67.877% |
| MacroGenics, Inc. | -168.24 Million USD | -107.676% |
| RenovoRx, Inc. | -11.39 Million USD | -2966.006% |
| Adicet Bio, Inc. | -152.03 Million USD | -129.812% |
| Prime Medicine, Inc. | -191.29 Million USD | -82.654% |
| Aditxt, Inc. | -26.06 Million USD | -1240.635% |
| Adagene Inc. | -23.71 Million USD | -1373.035% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4679.717% |
| Quantum-Si incorporated | -111.17 Million USD | -214.292% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1004.026% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2296.814% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 386.362% |
| SciSparc Ltd. | -5.77 Million USD | -5952.347% |
| Vericel Corporation | -6.46 Million USD | -5305.353% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -3936.22% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -1411.282% |
| Generation Bio Co. | -138.56 Million USD | -152.161% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -320.814% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -304.12% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -44.919% |
| Invivyd, Inc. | -207.78 Million USD | -68.157% |
| Relay Therapeutics, Inc. | -373 Million USD | 6.327% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -3625.562% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 1726.563% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -3296.539% |
| 2seventy bio, Inc. | -216.7 Million USD | -61.235% |
| ADMA Biologics, Inc. | 21.63 Million USD | 1715.209% |
| Clene Inc. | -40.54 Million USD | -761.87% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1351.134% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -537.641% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1206.521% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | 0.188% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -851.219% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 2273.303% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -236.929% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -927.592% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -105.195% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 48.941% |
| Evaxion Biotech A/S | -22.19 Million USD | -1474.096% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -324.124% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -56.595% |
| Trevena, Inc. | -35.28 Million USD | -890.144% |
| Surrozen, Inc. | -45.78 Million USD | -663.22% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -337.053% |
| Cingulate Inc. | -22.75 Million USD | -1435.213% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 4763.668% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -682.237% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -4143.436% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -240.687% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -376.161% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -462.88% |
| Clearmind Medicine Inc. | -8.74 Million USD | -3897.117% |
| Kronos Bio, Inc. | -121.83 Million USD | -186.795% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -358.557% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -11812.846% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -246.536% |
| Statera Biopharma, Inc. | -98.34 Million USD | -255.286% |
| ImmunityBio, Inc. | -362.25 Million USD | 3.547% |
| Korro Bio, Inc. | -84.53 Million USD | -313.327% |
| Kineta, Inc. | -15.72 Million USD | -2122.235% |
| BioVie Inc. | -32.17 Million USD | -985.788% |
| Codexis, Inc. | -68.06 Million USD | -413.306% |
| Celularity Inc. | -192.28 Million USD | -81.709% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -56.958% |
| Celcuity Inc. | -66.23 Million USD | -427.556% |
| Virax Biolabs Group Limited | -6.49 Million USD | -5278.334% |
| Cibus, Inc. | -318.88 Million USD | -9.571% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -712.563% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -932.39% |
| IN8bio, Inc. | -30.33 Million USD | -1051.736% |
| Kodiak Sciences Inc. | -277.32 Million USD | -25.992% |
| Annexon, Inc. | -143.72 Million USD | -143.108% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -182.252% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -440.485% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1390.369% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | 1.224% |
| Eyenovia, Inc. | -25.4 Million USD | -1275.249% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1170.472% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -6181.949% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -341.538% |
| Arcellx, Inc. | -89.88 Million USD | -288.743% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -669.405% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -154.653% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1023.154% |
| Moolec Science SA | -6.65 Million USD | -5151.161% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -471.497% |
| Geron Corporation | -193.94 Million USD | -80.156% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -707.81% |
| Royalty Pharma plc | 1.49 Billion USD | 123.416% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -112.84% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -3645.787% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -1495.832% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -104.38% |
| Humacyte, Inc. | -100.04 Million USD | -249.238% |
| Structure Therapeutics Inc. | -102.77 Million USD | -239.968% |
| 89bio, Inc. | -151.2 Million USD | -131.08% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -336.033% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -2303.04% |
| Genelux Corporation | -24.16 Million USD | -1345.901% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -929.986% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -103.436% |
| Notable Labs, Ltd. | -14.65 Million USD | -2283.858% |
| Liquidia Corporation | -73.38 Million USD | -376.128% |
| Mustang Bio, Inc. | -50.72 Million USD | -588.803% |
| Immunovant, Inc. | -282.7 Million USD | -23.591% |
| Quantum-Si incorporated | -111.17 Million USD | -214.292% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -347.361% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -1542.93% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -242.511% |
| Acasti Pharma Inc. | -11.31 Million USD | -2988.773% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -1424.368% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2086.583% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -63.231% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -9422.898% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2099.433% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1098.347% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -744.292% |
| PepGen Inc. | -84.76 Million USD | -312.196% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1079.177% |
| United Therapeutics Corporation | 1.18 Billion USD | 129.488% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1425.973% |
| Solid Biosciences Inc. | -104.31 Million USD | -234.949% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -964.986% |
| Immuneering Corporation | -58.41 Million USD | -498.159% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -6764.161% |
| Silo Pharma, Inc. | -3.85 Million USD | -8962.214% |
| Belite Bio, Inc | -31.66 Million USD | -1003.328% |
| XOMA Corporation | -41.84 Million USD | -734.931% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -417.479% |
| Bionomics Limited | -17.89 Billion USD | 98.047% |
| Apogee Therapeutics, Inc. | -93 Million USD | -275.689% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1079.266% |
| uniQure N.V. | -282.87 Million USD | -23.52% |
| Cassava Sciences, Inc. | -105.95 Million USD | -229.758% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4679.717% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -169.8% |
| Forte Biosciences, Inc. | -32.48 Million USD | -975.546% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -4105.227% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1088.644% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -6181.949% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -2358.846% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -3830.723% |
| Altimmune, Inc. | -95.92 Million USD | -264.23% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -375.416% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1079.266% |
| Compugen Ltd. | -12.99 Million USD | -2589.363% |
| Peak Bio, Inc. | -1356.23 USD | -25762639.358% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -604.383% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1453.588% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -44.2% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1074.618% |
| Zura Bio Limited | -62.63 Million USD | -457.812% |
| PolyPid Ltd. | -22.86 Million USD | -1427.975% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -2046.731% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1074.618% |
| Instil Bio, Inc. | -159.16 Million USD | -119.516% |
| argenx SE | -425.04 Million USD | 17.797% |
| Immunome, Inc. | -109.53 Million USD | -219.001% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -593.767% |
| Verona Pharma plc | -67.83 Million USD | -415.107% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1240.76% |
| Shattuck Labs, Inc. | -91.95 Million USD | -279.962% |
| CervoMed Inc. | -7.81 Million USD | -4372.119% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -377.913% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -2522.941% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -625.292% |
| Moolec Science SA | -6.65 Million USD | -5151.161% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -2024.226% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -158.382% |
| AnaptysBio, Inc. | -164.41 Million USD | -112.517% |
| Design Therapeutics, Inc. | -78.19 Million USD | -346.863% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -301.422% |
| NeurAxis, Inc. | -6.66 Million USD | -5142.738% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -762.742% |
| Lumos Pharma, Inc. | -36.61 Million USD | -854.285% |
| Achilles Therapeutics plc | -75.25 Million USD | -364.291% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1240.76% |
| 180 Life Sciences Corp. | -13.47 Million USD | -2492.484% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 6876.201% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -11812.846% |
| Nutriband Inc. | -4.87 Million USD | -7071.743% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -215.402% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -530.132% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -587.312% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -428.604% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -545.569% |
| Palisade Bio, Inc. | -13.07 Million USD | -2573.313% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -669.455% |
| Beam Therapeutics Inc. | -176.48 Million USD | -97.978% |
| Neurogene Inc. | -55.58 Million USD | -528.613% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -220.1% |
| AEON Biopharma, Inc. | -48.42 Million USD | -621.473% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -261.288% |
| Sesen Bio, Inc. | -25.9 Million USD | -1248.574% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -318.3% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -2675.919% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 24.135% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -382.34% |
| Athira Pharma, Inc. | -125.46 Million USD | -178.483% |
| Vaccinex, Inc. | -22.88 Million USD | -1426.773% |
| HCW Biologics Inc. | -25.71 Million USD | -1258.634% |
| XOMA Corporation | -41.84 Million USD | -734.931% |
| Nektar Therapeutics | -137.42 Million USD | -154.249% |
| Arvinas, Inc. | -401.5 Million USD | 12.976% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -3951057.013% |
| Merus N.V. | -156.54 Million USD | -123.193% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -248.492% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -909.249% |
| Rezolute, Inc. | -70.42 Million USD | -396.148% |
| Clene Inc. | -40.54 Million USD | -761.87% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -2033.3% |
| BeyondSpring Inc. | -23.11 Million USD | -1411.647% |
| Synlogic, Inc. | -55.16 Million USD | -533.422% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -1848.809% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -3128.03% |
| Peak Bio, Inc. | -1356.23 USD | -25762639.358% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -762.657% |
| Krystal Biotech, Inc. | -109.72 Million USD | -218.428% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -169.725% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -1.863% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -7262.104% |
| MannKind Corporation | 8.67 Million USD | 4126.296% |
| Ikena Oncology, Inc. | -75.41 Million USD | -363.293% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -3521.872% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -419.711% |
| Gossamer Bio, Inc. | -183.75 Million USD | -90.141% |
| CohBar, Inc. | -12.38 Million USD | -2720.42% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -588.83% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1166.546% |
| Legend Biotech Corporation | -439.48 Million USD | 20.497% |
| Mural Oncology plc | -194.63 Million USD | -79.514% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -420.385% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2064.114% |
| Disc Medicine, Inc. | -91.12 Million USD | -283.432% |
| Champions Oncology, Inc. | -7.35 Million USD | -4649.891% |
| REGENXBIO Inc. | -268.12 Million USD | -30.312% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3159.898% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -526.663% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -796.808% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -205.536% |
| Vaxart, Inc. | -83.34 Million USD | -319.214% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -4000.959% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -716.473% |
| Cellectis S.A. | -106.62 Million USD | -227.689% |
| Longeveron Inc. | -21.02 Million USD | -1561.525% |
| Repare Therapeutics Inc. | -116.22 Million USD | -200.628% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -30.46% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -361.897% |
| Revolution Medicines, Inc. | -487.18 Million USD | 28.281% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -5152.586% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -694.927% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -368.43% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -401.762% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -3073.209% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 108.111% |
| Denali Therapeutics Inc. | -196.69 Million USD | -77.633% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -3936.22% |
| Veru Inc. | -93.78 Million USD | -272.567% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1397.715% |
| Cingulate Inc. | -22.75 Million USD | -1435.213% |
| Passage Bio, Inc. | -108.38 Million USD | -222.359% |
| Context Therapeutics Inc. | -25.07 Million USD | -1293.56% |
| Exicure, Inc. | -14.99 Million USD | -2229.968% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -69.56% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -760.638% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -3495.804% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -89.525% |
| Nuvalent, Inc. | -149.49 Million USD | -133.726% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -4152.439% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -293.777% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -1581.92% |
| OmniAb, Inc. | -69.41 Million USD | -403.323% |
| Anew Medical, Inc. | -1.3 Million USD | -26759.721% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -2635.902% |
| Lipocine Inc. | -17.93 Million USD | -1848.596% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -409.979% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -358.822% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -817.66% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -783.958% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -1460.945% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 39.743% |
| Ocugen, Inc. | -65.53 Million USD | -433.186% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -272.235% |
| Q32 Bio Inc. | -92.1 Million USD | -279.364% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -1529.75% |
| Alumis Inc. Common Stock | -158.17 Million USD | -120.897% |
| Equillium, Inc. | -14.52 Million USD | -2306.018% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -459.885% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -4320.936% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1752.107% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -644.184% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -222.13% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -2818.977% |
| Dominari Holdings Inc. | -21.79 Million USD | -1503.056% |
| Edesa Biotech, Inc. | -9.22 Million USD | -3688.476% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1270.096% |
| Bio-Techne Corporation | 206.68 Million USD | 269.05% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 10.75% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 281.952% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -164.144% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -810.114% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -131.237% |
| Nkarta, Inc. | -131.65 Million USD | -165.402% |
| BioCardia, Inc. | -11.64 Million USD | -2900.704% |
| Iterum Therapeutics plc | -47.46 Million USD | -636.079% |